HEADER HYDROLASE/HYDROLASE INHIBITOR 14-OCT-10 3P8O TITLE CRYSTAL STRUCTURE OF HCV NS3/NS4A PROTEASE COMPLEXED WITH DES-BROMINE TITLE 2 ANALOGUE OF BI 201335 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HCV SERINE PROTEASE NS3; COMPND 3 CHAIN: A, B; COMPND 4 EC: 3.4.21.98; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: HCV NON-STRUCTURAL PROTEIN 4A; COMPND 8 CHAIN: C, D; COMPND 9 FRAGMENT: NS3 INTERACTING PEPTIDE; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HEPATITIS C VIRUS; SOURCE 3 ORGANISM_COMMON: HCV; SOURCE 4 ORGANISM_TAXID: 11116; SOURCE 5 STRAIN: ISOLATE JAPANESE; SOURCE 6 GENE: POLG_HCVJA; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES KEYWDS HEPATITIS C VIRUS, NS3, NS4A, HALOGEN BOND, SERINE PROTEASE, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.T.LEMKE REVDAT 4 08-NOV-17 3P8O 1 REMARK REVDAT 3 15-JUN-11 3P8O 1 JRNL REVDAT 2 09-FEB-11 3P8O 1 JRNL REVDAT 1 26-JAN-11 3P8O 0 JRNL AUTH C.T.LEMKE,N.GOUDREAU,S.ZHAO,O.HUCKE,D.THIBEAULT, JRNL AUTH 2 M.LLINAS-BRUNET,P.W.WHITE JRNL TITL COMBINED X-RAY, NMR, AND KINETIC ANALYSES REVEAL UNCOMMON JRNL TITL 2 BINDING CHARACTERISTICS OF THE HEPATITIS C VIRUS NS3-NS4A JRNL TITL 3 PROTEASE INHIBITOR BI 201335. JRNL REF J.BIOL.CHEM. V. 286 11434 2011 JRNL REFN ISSN 0021-9258 JRNL PMID 21270126 JRNL DOI 10.1074/JBC.M110.211417 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.9 REMARK 3 NUMBER OF REFLECTIONS : 17940 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.255 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.700 REMARK 3 FREE R VALUE TEST SET COUNT : 872 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2834 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 114 REMARK 3 SOLVENT ATOMS : 66 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.41 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.11400 REMARK 3 B22 (A**2) : 0.11400 REMARK 3 B33 (A**2) : -0.22700 REMARK 3 B12 (A**2) : 0.03600 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.609 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.740 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.311 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.277 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ION.PARAM REMARK 3 PARAMETER FILE 5 : BI00201335_MOD.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ION.TOP REMARK 3 TOPOLOGY FILE 5 : BI00201335_MOD.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3P8O COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 22-OCT-10. REMARK 100 THE DEPOSITION ID IS D_1000062095. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18452 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 10.60 REMARK 200 R MERGE (I) : 0.04800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.6 REMARK 200 DATA REDUNDANCY IN SHELL : 7.70 REMARK 200 R MERGE FOR SHELL (I) : 0.38300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 3M NACL, 0.1M NA CITRATE, 2.5% T REMARK 280 -BUTANOL, 20MM OBG, 5MM DTT, 3MM SODIUM AZIDE, PH 6.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 27.26667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 54.53333 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 40.90000 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 68.16667 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 13.63333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2500 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8880 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 8920 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 183 REMARK 465 LYS A 184 REMARK 465 LYS A 185 REMARK 465 LYS A 186 REMARK 465 LYS B 183 REMARK 465 LYS B 184 REMARK 465 LYS B 185 REMARK 465 LYS B 186 REMARK 465 LYS C 219 REMARK 465 GLY C 233 REMARK 465 ARG C 234 REMARK 465 LYS C 235 REMARK 465 LYS D 219 REMARK 465 GLY D 233 REMARK 465 ARG D 234 REMARK 465 LYS D 235 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 180 CG CD NE CZ NH1 NH2 REMARK 470 SER A 182 OG REMARK 470 ARG B 180 CG CD NE CZ NH1 NH2 REMARK 470 SER B 182 OG REMARK 470 LYS C 220 CB CG CD CE NZ REMARK 470 LYS D 220 CB CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 38 -167.05 -111.96 REMARK 500 ALA A 181 34.85 -81.34 REMARK 500 THR B 38 -157.58 -111.60 REMARK 500 VAL B 172 -3.62 -59.60 REMARK 500 ARG B 180 43.38 -79.99 REMARK 500 ALA B 181 -13.19 -147.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 L5T B 188 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 187 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ALA A 5 O REMARK 620 2 ALA A 111 O 99.2 REMARK 620 3 HOH A 197 O 96.7 102.0 REMARK 620 4 HOH A 196 O 84.8 168.3 88.3 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA B 187 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ALA B 111 O REMARK 620 2 ALA B 5 O 88.9 REMARK 620 3 HOH B 207 O 96.4 158.7 REMARK 620 4 HOH B 193 O 100.0 83.2 75.5 REMARK 620 N 1 2 3 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE ENZYME INHIBITOR REMARK 630 MOLECULE NAME: N-[(CYCLOPENTYLOXY)CARBONYL]-3-METHYL-L-VALYL-(4R)- REMARK 630 N-[(1R,2S)-1-CARBOXY-2-ETHENYLCYCLOPROPYL]-4-[(7-METHOXY-2-{2-[(2- REMARK 630 METHYLPROPANOYL)AMINO]-1,3-THIAZOL-4-YL}QUINOLIN-4-YL)OXY]-L- REMARK 630 PROLINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 L5T A 188 REMARK 630 L5T B 188 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 12W TBG 12Y 0Y9 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA A 187 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L5T A 188 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA B 187 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE L5T B 188 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3P8N RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THESE ARE NATURAL VARIANTS ACCORDING TO UNIPROT. DBREF 3P8O A 1 180 UNP P26662 POLG_HCVJA 1027 1206 DBREF 3P8O B 1 180 UNP P26662 POLG_HCVJA 1027 1206 DBREF 3P8O C 219 235 PDB 3P8O 3P8O 219 235 DBREF 3P8O D 219 235 PDB 3P8O 3P8O 219 235 SEQADV 3P8O ILE A 114 UNP P26662 VAL 1140 SEE REMARK 999 SEQADV 3P8O VAL A 132 UNP P26662 ILE 1158 SEE REMARK 999 SEQADV 3P8O ALA A 181 UNP P26662 EXPRESSION TAG SEQADV 3P8O SER A 182 UNP P26662 EXPRESSION TAG SEQADV 3P8O LYS A 183 UNP P26662 EXPRESSION TAG SEQADV 3P8O LYS A 184 UNP P26662 EXPRESSION TAG SEQADV 3P8O LYS A 185 UNP P26662 EXPRESSION TAG SEQADV 3P8O LYS A 186 UNP P26662 EXPRESSION TAG SEQADV 3P8O ILE B 114 UNP P26662 VAL 1140 SEE REMARK 999 SEQADV 3P8O VAL B 132 UNP P26662 ILE 1158 SEE REMARK 999 SEQADV 3P8O ALA B 181 UNP P26662 EXPRESSION TAG SEQADV 3P8O SER B 182 UNP P26662 EXPRESSION TAG SEQADV 3P8O LYS B 183 UNP P26662 EXPRESSION TAG SEQADV 3P8O LYS B 184 UNP P26662 EXPRESSION TAG SEQADV 3P8O LYS B 185 UNP P26662 EXPRESSION TAG SEQADV 3P8O LYS B 186 UNP P26662 EXPRESSION TAG SEQRES 1 A 186 ALA PRO ILE THR ALA TYR SER GLN GLN THR ARG GLY LEU SEQRES 2 A 186 LEU GLY CYS ILE ILE THR SER LEU THR GLY ARG ASP LYS SEQRES 3 A 186 ASN GLN VAL ASP GLY GLU VAL GLN VAL LEU SER THR ALA SEQRES 4 A 186 THR GLN SER PHE LEU ALA THR CYS VAL ASN GLY VAL CYS SEQRES 5 A 186 TRP THR VAL TYR HIS GLY ALA GLY SER LYS THR LEU ALA SEQRES 6 A 186 GLY PRO LYS GLY PRO ILE THR GLN MET TYR THR ASN VAL SEQRES 7 A 186 ASP GLN ASP LEU VAL GLY TRP PRO ALA PRO PRO GLY ALA SEQRES 8 A 186 ARG SER MET THR PRO CYS THR CYS GLY SER SER ASP LEU SEQRES 9 A 186 TYR LEU VAL THR ARG HIS ALA ASP VAL ILE PRO VAL ARG SEQRES 10 A 186 ARG ARG GLY ASP SER ARG GLY SER LEU LEU SER PRO ARG SEQRES 11 A 186 PRO VAL SER TYR LEU LYS GLY SER SER GLY GLY PRO LEU SEQRES 12 A 186 LEU CYS PRO SER GLY HIS VAL VAL GLY ILE PHE ARG ALA SEQRES 13 A 186 ALA VAL CYS THR ARG GLY VAL ALA LYS ALA VAL ASP PHE SEQRES 14 A 186 ILE PRO VAL GLU SER MET GLU THR THR MET ARG ALA SER SEQRES 15 A 186 LYS LYS LYS LYS SEQRES 1 B 186 ALA PRO ILE THR ALA TYR SER GLN GLN THR ARG GLY LEU SEQRES 2 B 186 LEU GLY CYS ILE ILE THR SER LEU THR GLY ARG ASP LYS SEQRES 3 B 186 ASN GLN VAL ASP GLY GLU VAL GLN VAL LEU SER THR ALA SEQRES 4 B 186 THR GLN SER PHE LEU ALA THR CYS VAL ASN GLY VAL CYS SEQRES 5 B 186 TRP THR VAL TYR HIS GLY ALA GLY SER LYS THR LEU ALA SEQRES 6 B 186 GLY PRO LYS GLY PRO ILE THR GLN MET TYR THR ASN VAL SEQRES 7 B 186 ASP GLN ASP LEU VAL GLY TRP PRO ALA PRO PRO GLY ALA SEQRES 8 B 186 ARG SER MET THR PRO CYS THR CYS GLY SER SER ASP LEU SEQRES 9 B 186 TYR LEU VAL THR ARG HIS ALA ASP VAL ILE PRO VAL ARG SEQRES 10 B 186 ARG ARG GLY ASP SER ARG GLY SER LEU LEU SER PRO ARG SEQRES 11 B 186 PRO VAL SER TYR LEU LYS GLY SER SER GLY GLY PRO LEU SEQRES 12 B 186 LEU CYS PRO SER GLY HIS VAL VAL GLY ILE PHE ARG ALA SEQRES 13 B 186 ALA VAL CYS THR ARG GLY VAL ALA LYS ALA VAL ASP PHE SEQRES 14 B 186 ILE PRO VAL GLU SER MET GLU THR THR MET ARG ALA SER SEQRES 15 B 186 LYS LYS LYS LYS SEQRES 1 C 17 LYS LYS GLY SER VAL VAL ILE VAL GLY ARG ILE ILE LEU SEQRES 2 C 17 SER GLY ARG LYS SEQRES 1 D 17 LYS LYS GLY SER VAL VAL ILE VAL GLY ARG ILE ILE LEU SEQRES 2 D 17 SER GLY ARG LYS HET NA A 187 1 HET L5T A 188 56 HET NA B 187 1 HET L5T B 188 56 HETNAM NA SODIUM ION HETNAM L5T N-[(CYCLOPENTYLOXY)CARBONYL]-3-METHYL-L-VALYL-(4R)-N- HETNAM 2 L5T [(1R,2S)-1-CARBOXY-2-ETHENYLCYCLOPROPYL]-4-[(7- HETNAM 3 L5T METHOXY-2-{2-[(2-METHYLPROPANOYL)AMINO]-1,3-THIAZOL-4- HETNAM 4 L5T YL}QUINOLIN-4-YL)OXY]-L-PROLINAMIDE FORMUL 5 NA 2(NA 1+) FORMUL 6 L5T 2(C40 H50 N6 O9 S) FORMUL 9 HOH *66(H2 O) HELIX 1 1 GLY A 12 GLY A 23 1 12 HELIX 2 2 VAL A 55 GLY A 60 1 6 HELIX 3 3 VAL A 132 LYS A 136 1 5 HELIX 4 4 GLU A 173 ALA A 181 1 9 HELIX 5 5 GLY B 12 GLY B 23 1 12 HELIX 6 6 TYR B 56 GLY B 60 1 5 HELIX 7 7 VAL B 132 LYS B 136 1 5 HELIX 8 8 VAL B 172 ARG B 180 1 9 SHEET 1 A 7 THR A 4 GLN A 9 0 SHEET 2 A 7 VAL C 224 SER C 232 -1 O ILE C 230 N TYR A 6 SHEET 3 A 7 VAL A 33 SER A 37 -1 N VAL A 35 O GLY C 227 SHEET 4 A 7 SER A 42 VAL A 48 -1 O PHE A 43 N LEU A 36 SHEET 5 A 7 VAL A 51 THR A 54 -1 O TRP A 53 N THR A 46 SHEET 6 A 7 LEU A 82 PRO A 86 -1 O TRP A 85 N CYS A 52 SHEET 7 A 7 TYR A 75 ASN A 77 -1 N ASN A 77 O LEU A 82 SHEET 1 B 7 ASP A 103 VAL A 107 0 SHEET 2 B 7 VAL A 113 ARG A 118 -1 O VAL A 116 N LEU A 104 SHEET 3 B 7 ARG A 123 PRO A 131 -1 O SER A 125 N ARG A 117 SHEET 4 B 7 VAL A 163 PRO A 171 -1 O ALA A 164 N ARG A 130 SHEET 5 B 7 VAL A 150 THR A 160 -1 N ALA A 156 O ASP A 168 SHEET 6 B 7 PRO A 142 LEU A 144 -1 N LEU A 143 O VAL A 151 SHEET 7 B 7 ASP A 103 VAL A 107 -1 N TYR A 105 O LEU A 144 SHEET 1 C 7 ALA B 5 GLN B 9 0 SHEET 2 C 7 VAL D 224 LEU D 231 -1 O ILE D 230 N TYR B 6 SHEET 3 C 7 VAL B 33 SER B 37 -1 N VAL B 35 O GLY D 227 SHEET 4 C 7 SER B 42 VAL B 48 -1 O PHE B 43 N LEU B 36 SHEET 5 C 7 VAL B 51 VAL B 55 -1 O TRP B 53 N THR B 46 SHEET 6 C 7 LEU B 82 PRO B 86 -1 O TRP B 85 N CYS B 52 SHEET 7 C 7 TYR B 75 ASN B 77 -1 N ASN B 77 O LEU B 82 SHEET 1 D 7 ASP B 103 VAL B 107 0 SHEET 2 D 7 VAL B 113 ARG B 118 -1 O VAL B 116 N LEU B 104 SHEET 3 D 7 ARG B 123 PRO B 131 -1 O SER B 125 N ARG B 117 SHEET 4 D 7 VAL B 163 PRO B 171 -1 O VAL B 167 N GLY B 124 SHEET 5 D 7 VAL B 150 THR B 160 -1 N ALA B 156 O ASP B 168 SHEET 6 D 7 PRO B 142 LEU B 144 -1 N LEU B 143 O GLY B 152 SHEET 7 D 7 ASP B 103 VAL B 107 -1 N TYR B 105 O LEU B 144 SSBOND 1 CYS A 97 CYS A 145 1555 1555 2.04 SSBOND 2 CYS B 97 CYS B 145 1555 1555 2.04 LINK O ALA A 5 NA NA A 187 1555 1555 1.98 LINK O ALA B 111 NA NA B 187 1555 1555 2.25 LINK O ALA A 111 NA NA A 187 1555 1555 2.30 LINK O ALA B 5 NA NA B 187 1555 1555 2.50 LINK NA NA B 187 O HOH B 207 1555 1555 2.45 LINK NA NA A 187 O HOH A 197 1555 1555 2.52 LINK NA NA B 187 O HOH B 193 1555 1555 2.63 LINK NA NA A 187 O HOH A 196 1555 1555 2.68 SITE 1 AC1 4 ALA A 5 ALA A 111 HOH A 196 HOH A 197 SITE 1 AC2 18 TYR A 56 HIS A 57 VAL A 78 ASP A 81 SITE 2 AC2 18 LEU A 135 LYS A 136 GLY A 137 SER A 138 SITE 3 AC2 18 SER A 139 PHE A 154 ARG A 155 ALA A 156 SITE 4 AC2 18 ALA A 157 VAL A 158 CYS A 159 ASP A 168 SITE 5 AC2 18 HOH A 209 HOH A 216 SITE 1 AC3 4 ALA B 5 ALA B 111 HOH B 193 HOH B 207 SITE 1 AC4 19 TYR B 56 HIS B 57 VAL B 78 ASP B 81 SITE 2 AC4 19 ARG B 123 VAL B 132 LEU B 135 LYS B 136 SITE 3 AC4 19 GLY B 137 SER B 138 SER B 139 PHE B 154 SITE 4 AC4 19 ARG B 155 ALA B 156 ALA B 157 CYS B 159 SITE 5 AC4 19 HOH B 208 HOH B 220 HOH B 222 CRYST1 94.965 94.965 81.800 90.00 90.00 120.00 P 61 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010530 0.006080 0.000000 0.00000 SCALE2 0.000000 0.012159 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012225 0.00000